Biotech co Kamada gets sales OK in Russia
June 1, 2010 by biotechcheck.com · Leave a Comment
Biotech co Kamada gets income OK in Russia
The drug will be marketed under the study “RespiKam”.
Read more on Globes Online
The Biotech Entrepreneur’s Glossary: Including Terms In Accounting, Biotechnology, Business, Computers, Fund Acquisition, Human Resources, Law, Patents, Marketing And Sales – With Eight Appendices
May 27, 2010 by biotechcheck.com · 5 Comments
Product Description
This book will assist you in understanding the practical terms encompassing the operation of a biotechnology firm. Terms used in bookkeeping and auditing, biotechnology (including agribiotech, fermentation science, genetics/genomics, immunology, molecular biology, calibre assurance and calibre control), personal (software, hardware and the internet), day-to-day business (communications, financing, fund acquisition, grants, product manufacture, transportation, and handling), human resources, patents and filing, legal, marketing and sales, are precisely defined, with cross references and examples where appropriate.
In addition, eight appendices containing: 1) abbreviations and acronyms used in biotechnology; 2) addresses of biotechnology recruiters; 3) domestic and foreign venture capitalists (including mailing addresses, telephone/Fax numbers, and E-mail addresses); 4) Institutes and Centers comprising the National Institutes of Health that honor Small Business Innovation Research (SBIR) allows and contracts; 5) laws and regulations governing the receipt of federal grants, and; 6) tables related to molecular biology and genetics. They say, “Knowledge is power!” This book should greatly increase your knowledge of the working terms and therefore the work performed within apiece department in biotechnology firms, making you more productive and enhancing your entrepreneurial skills.
BTG sales rise 16.2 percent
May 22, 2010 by biotechcheck.com · Leave a Comment
BTG income rise 16.2 percent
LONDON (Reuters) – Pharmaceutical firm BTG ( BGC.L ) stated it would market its varicose vein treatment Varisolve itself in the United States, after a strong financial performance in the year to end-March.
Read more on Interactive Investor
Recession hits ELSB’s European sales
May 1, 2010 by biotechcheck.com · Leave a Comment
Recession hits ELSB’s European sales
JOHOR BARU: Equator Life Science Bhd (ELSB) stated the global economic recession in the last two years has caused income of its ornamental plants in Europe to start by 37%.
Read more on The Star
Sartorius Group’s first-quarter consolidated sales revenue increases by 3.0% to 150.4 million euros
April 23, 2010 by biotechcheck.com · Leave a Comment
Sartorius Group’s first-quarter consolidated income revenue increases by 3.0% to 150.4 million euros
At today’s Annual Shareholders’ Meeting of the Sartorius technology group, CEO and Executive Board Chairman Dr. Joachim Kreuzburg presented the consolidated results for the first three months of 2010. The Biotech Division, which operates under the study Sartorius Stedim Biotech and contributes a good two-thirds to consolidated sales, started off the year 2010 by reporting growth and further …
Read more on News-Medical-Net
















